Causal relationships between type 1 diabetes mellitus and Alzheimer’s disease and Parkinson’s disease: a bidirectional two-sample Mendelian randomization study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Causal relationships between type 1 diabetes mellitus and Alzheimer’s disease and Parkinson’s disease: a bidirectional two-sample Mendelian randomization study ; volume:29 ; number:1 ; day:16 ; month:1 ; year:2024 ; pages:1-10 ; date:12.2024
European journal of medical research ; 29, Heft 1 (16.1.2024), 1-10, 12.2024
- Urheber
-
Geng, Chaofan
Meng, Ke
Zhao, Bo
Liu, Xiaoduo
Tang, Yi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40001-023-01628-z
- URN
-
urn:nbn:de:101:1-2024032722233640694834
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Geng, Chaofan
- Meng, Ke
- Zhao, Bo
- Liu, Xiaoduo
- Tang, Yi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer’s disease
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer’s disease
SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer’s disease
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer’s disease
SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer’s disease
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer’s disease
SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease
Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia